MedPath

Mytogen, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
5K
Market Cap
-
Website
http://www.mytogen.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System

Phase 2
Conditions
Ischemic Cardiomyopathy
First Posted Date
2008-02-29
Last Posted Date
2008-02-29
Lead Sponsor
Mytogen, Inc.
Target Recruit Count
165
Registration Number
NCT00626314
Locations
🇺🇸

Mercy Gilbert, Gilbert, Arizona, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath